Ideas

May 20, 2018

Published by admin_auro at May 20, 2018

Categories

Molecular therapy for cardiomyocyte proliferation and heart regeneration: A pharmaceutical mixture encompassing 3,3′-Diindolylmethane (DIM) Sodium nitrite(NaNO2), and Sodium Sulfide (DIMSNSS) decreases tumor suppressor MiR-128 and cyclin-dependent kinase inhibitor p27 expression, increases SUZ12 expression, increases Cyclin E and CDK2 expression, promotes proliferation/re-entry of postnatal/adult cardiomyocytes, attenuates fibrosis, ameliorates cardiac dysfunction, and promotes heart repair in response to myocardial infarction, via up regulation of its target gene, 20/May/2018, 4.29 pm

Introduction: What they say: A recent study from Department of Pathology and Laboratory Medicine, University of Cincinnati College of Medicine, Cincinnati, OH, 45267, USA; Key Laboratory […]

May 20, 2018

Published by admin_auro at May 20, 2018

Categories

A sweet way to strengthen your heart-too good to be true(!): Oligofructose-based therapy for Cardiomyopathy: Agavins (Oligofructose),isolated from agavi, may suppress tumor suppressor INK4a/p16 expression, and inhibit dilated cardiomyopathy, via up regulation of its target gene, 20/May/2018, 3.36 pm

What we say: Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: A sweet way to strengthen your heart-too good to be true(!): Oligofructose-based therapy for Cardiomyopathy: Agavins […]

May 18, 2018

Published by admin_auro at May 18, 2018

Categories

A glycolipid-based therapy for glucose homeostasis and TIIDM: α-Galactosylceramide (α-gal-cer), a synthetic glycolipid, increases Pax6 and insulin expression, decreases the levels of glucagon, ghrelin and Somatostatin, reduces metabolic stress, improves insulin sensitivity, promotes glucose homeostasis and prevents progression to TIIDM via down regulation of its target gene, 18/May/2018, 2.03 pm

Introduction: What they say A study from the Department of Developmental Biology and Cancer Research, The Institute for Medical Research Israel-Canada, The Hebrew University-Hadassah Medical School, […]

May 18, 2018

Published by admin_auro at May 18, 2018

Categories

Glycolipid-based Lifespan extension therapy: α-galactosylceramide (α-GalCer), a synthetic glycolipid, increases life span via up-regulation of its target gene BubR1, 18/May/2018, 1.29 pm

What they say: Introduction: A recent study from the Department of Genetics, Paul F. Glenn Laboratories for the Biological Mechanisms of Aging Harvard Medical School, Boston,USA; and […]